NASD · Healthcare · Medical Care Facilities · USA
biote Corp is a micro cap company (market value under $300 million) in the Medical Care Facilities industry.
Biote Corp operates a practice-building platform for hormone optimization serving healthcare practitioners. The company provides training, certification, practice management software, inventory tools, and marketing support to enable practitioners to establish and operate hormone optimization programs. Biote also sells a complementary line of dietary supplements and generates revenue through service agreements with partnered clinics and supplement sales.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the biote Corp stock.
No reliable verdict: intrinsic value $8.65 per share, market price $0.99 (as of 2026-11-17).
Discounting its cash flows would put the shares at $8.65: 9 times the price of $0.99. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
5 more funds hold it; the full list is part of the paid plan.
All 48 Medical Care Facilities stocks
We do not publish a verdict on BTMD. Discounting its cash flows would put the shares at $8.65: 9 times the price of $0.99. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
We do not publish one (as of the 2026-11-17 close). Discounting its cash flows would put the shares at $8.65: 9 times the price of $0.99. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.